SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

Crowdstrike is trending as the cybersecurity sector faces a significant sell-off, fueled by fears that Anthropic's Claude Code Security tool could disrupt traditional software. This has sparked intense debate among investors, with many calling the sharp decline an overreaction and a buying opportunity, asserting that Claude's functionality does not directly compete with Crowdstrike's core offerings.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending after receiving FDA approval for BYSANTI, a new chemical entity with patent protection until 2044 for treating bipolar I disorder and schizophrenia. The community is actively debating the stock's significant undervaluation given this second recent approval, speculating on a potential buyout by larger pharmaceutical companies.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

International Business Machines is experiencing significant volatility, fueled by aggressive put buying and concerns that AI could disrupt its legacy offerings, despite recent strong earnings and strategic advancements in enterprise AI and quantum computing. The community remains divided, with some questioning the sudden decline amid a broader software sector pullback, while others view it as an oversold buying opportunity.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is trending as it hits new all-time lows following news of a 12% workforce layoff, intensifying community speculation about its financial viability, potential for bankruptcy, and future dilution amidst a challenging EV market.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscaler is experiencing a significant downturn, with community debate raging over whether fears of AI-driven obsolescence, particularly from Anthropic's Claude Code Security, justify the extensive sell-off across the cybersecurity sector. While some predict further declines due to AI disruption, many view the stock as fundamentally oversold and a generational buying opportunity.

BlackRock Institutional Trust Company N.A. - iShares Expanded Tech-Software Sector ETF

iShares Expanded Tech-Software Sector ETF

The iShares Expanded Tech-Software Sector ETF (IGV) is trending due to a sharp sell-off, fueled by widespread community discussion around AI, particularly Anthropic's Claude, potentially disrupting traditional enterprise software. Despite the ETF hitting multi-year lows and whispers of a "SaaSpocalypse," many investors are now considering the oversold sector as a long-term opportunity amidst perceived market overreaction.

Mastercard, Inc. is a technology company, which engages in the provision of payment solutions for the development and implementation of credit, debit, prepaid, commercial, and payment programs through its brands including Mastercard, Maestro, and Cirrus. It also offers cyber and intelligence solutions. The company was founded in November 1966 and is headquartered in Purchase, NY.

Mastercard Incorporated - Ordinary Shares - Class A

Mastercard Inc

Mastercard is trending due to its proactive integration of AI in payments and robust earnings report, while the community actively debates both the disruptive potential of AI in financial services and the indirect market impact of proposed credit card regulations.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is trending due to widespread reports of attracting unsolicited takeover interest, with potential suitors eyeing either the entire company or valuable assets like Venmo. The community is actively debating prospective acquirers and speculating on buyout prices significantly above current levels, fueled by perceptions of the company's undervaluation and strong cash flow despite its recent stock slump and impending leadership change.

Blackboxstocks, Inc. engages in the operation of a financial technology and social media platform. It offers real-time proprietary analytics and news for stock and option traders. The company was founded by Gust Kepler, Eric Pharis and David Kyle on October 4, 2011 and is headquartered in Dallas, TX.

Blackboxstocks Inc

The impending merger with REalloys Inc. is driving immense interest in BLBX, as REalloys actively builds out a North American mine-to-magnet rare earth supply chain. Community discussions are highlighting the recent effectiveness of the merger's S-4, substantial U.S. EXIM Bank financing, strategic board additions including high-profile defense and finance leaders, and key international partnerships, positioning the combined entity as a significant player in critical minerals.

Avalanche is a high throughput smart contract blockchain platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is trending as its price experiences multi-year lows, leading to widespread community frustration and debate, especially following a recent token unlock event and disappointing zero inflows into the newly launched VanEck spot ETF.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CADL Imagine being able to buy shares in a company that has $350 million COH, very little debt &amp; a $15-20 BILLION drug that has passed the FDA design approved Phase 3 trials with solid results &amp; safety testing. 

But, wait…there’s more! The company’s drug is also in advanced stages of development for several additional indications with remarkable success at every phase, which each address TAMs in the $10’s of BILLIONS. 

But, wait…there’s even more! Multiple Major Biotech Investment Funds are accumulating large positions in the Company’s stock. 

But, wait…there’s still more! The company is right now preparing its NDA filing with the FDA for commercial authorization for its $15-$20 BILLION TAM drug by the 4th quarter of this year, which is just 6 months away! 

But, wait…the best part is that right now you can buy shares of this company (CADL), which has fewer than 75 million shares outstanding following its latest cash raise, while the market cap is still at only $267 million!

Todd Luttenegger

Capt Bob

CO145

John Thrower

Richard

eagles155

Greyhound9

Gregory Smock

StockTwits for iOS

Candel Therapeutics Inc

 Imagine being able to buy shares in a company that has $350 million COH, very little debt & a $15-20 BILLION drug that has passed the FDA design approved Phase 3 trials with solid results & safety testing. 

But, wait…there’s more! The company’s drug is also in advanced stages of development for several additional indications with remarkable success at every phase, which each address TAMs in the $10’s of BILLIONS. 

But, wait…there’s even more! Multiple Major Biotech Investment Funds are accumulating large positions in the Company’s stock. 

But, wait…there’s still more! The company is right now preparing its NDA filing with the FDA for commercial authorization for its $15-$20 BILLION TAM drug by the 4th quarter of this year, which is just 6 months away! 

But, wait…the best part is that right now you can buy shares of this company (CADL), which has fewer than 75 million shares outstanding following its latest cash raise, while the market cap is still at only $267 million!

wesley thompson

@5StarTrader   HUH?????????????????????????? 
YOU BETTER do more MATH!!!!!!!!!!!!!!!!!!!!!!!!!!!! 
 
Certainly not 5 Star 
 
1st they dont have 350 COH ..... 
2nd  ......if the Trinity deal completes ....doubtful ... 
would be 130 mil IN DEBT &lt;&lt;&lt;&lt;&lt;&lt;&lt;&lt;&lt;&lt;&lt;&lt;&lt;  now its 50 
 
15=20 BIL TAM   LOL LOL LOL .............for prostate ...LAUGHABLE ....maybe  1-2 bil a year  depending on pricing

StockTwits Web

   HUH?????????????????????????? 
YOU BETTER do more MATH!!!!!!!!!!!!!!!!!!!!!!!!!!!! 
 
Certainly not 5 Star 
 
1st they dont have 350 COH ..... 
2nd  ......if the Trinity deal completes ....doubtful ... 
would be 130 mil IN DEBT <<<<<<<<<<<<<  now its 50 
 
15=20 BIL TAM   LOL LOL LOL .............for prostate ...LAUGHABLE ....maybe  1-2 bil a year  depending on pricing